Amblyopia: Nursing

Amblyopia: Nursing

nancy

nancy

Pharmacokinetics - Absorption: Nursing pharmacology
Medication administration - Safety principles: Nursing pharmacology
Pharmacokinetics - Elimination: Nursing pharmacology
Pharmacokinetics - Distribution: Nursing pharmacology
Pharmacokinetics - Metabolism: Nursing pharmacology
Care of a client identifying as LGBTQ+: Nursing
Health and illness models: Nursing
Core measures: Nursing
Public health nursing: Nursing
Healthcare costs: Nursing
Health promotion and illness prevention: Nursing
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antiemetics: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Laxatives: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Physiology of pain: Nursing
Pain
Vital signs - Pain: Nursing skills
Alpha-1 adrenergic blockers: Nursing pharmacology
Alpha-2 adrenergic agonists: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antiarrhythmics: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Cholinergic therapy - Overview: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Nitrates: Nursing pharmacology
Sympathomimetic medications: Nursing pharmacology
Amblyopia: Nursing
Cataracts: Nursing
Detached retina: Nursing
Hearing impairment and otosclerosis: Nursing
Legal blindness: Nursing
Macular degeneration: Nursing
Meniere disease: Nursing
Pharyngitis: Nursing
Retinoblastoma: Nursing
Strabismus: Nursing
Evidence-based practice (EBP): Nursing
Antiglaucoma medications: Nursing pharmacology
Acne: Nursing
Medications for acne vulgaris: Nursing pharmacology
Insulin: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Antipsychotics: Nursing pharmacology
Grief and loss: Nursing
Stress and coping: Nursing

Notes

AMBLYOPIA

KEY POINTS
NOTES
DEFINITION
  • Reduced vision in one eye
  • "Lazy eye"

PHYSIOLOGY
  • Visual development
    • Begins in first few days following birth
  • Visual pathway
    • Cornea
    • Sclera
    • Lens
    • Retina
    • Optic disc
    • Visual cortex

CAUSES AND RISK FACTORS
  • Causes
    • Any condition that interferes with visual development
  • Risk factors
    • Family history
    • Premature birth
    • Neurodevelopmental disorders

PATHOPHYSIOLOGY
  • Eye doesn't receive visual stimuli during development
  • Abnormal visual development
  • Visual cortex can't fuse images
  • Visual cortex ignores images from affected eye
  • Affected eye weakens
  • Complications
    • Blindness

SIGNS AND SYMPTOMS
  • Diminished vision
  • Wandering eye
  • Squinting head tilting
  • Blindness

DIAGNOSIS
  • History
  • Physical assessment
  • Red reflex test
  • Stereopsis test
  • Occlusion-objection test
  • Titmus test
  • Visual fixation
  • Visual acuity

TREATMENT
  • Patching
  • Eye drops
  • Glasses
  • Underlying cause

MANAGEMENT OF CARE
  • Goals of care
    • Provide supportive care
    • Monitor for adherence
  • Assess affected eye
  • Cover stronger eye
  • Talk to child using simple, easy language
  • Monitor at regular intervals

PATIENT AND FAMILY TEACHING
  • Explain condition, plan of care, and how to safely administer medications
  • Reassure caregivers
  • Remind caregivers to explain plan of care to teachers and school nurse
  • Teach how to apply patch
  • Instruct to monitor skin
    • Notify HCP
      • Unresolved skin irritation
  • Caution with activities
  • Keep all follow-up appointments
  • Notify HCP
    • No improvement
    • Symptoms worsening

Transcript

Watch video only

Amblyopia is a condition in which there’s reduced vision in one eye due to abnormal visual development. Amblyopia is commonly referred to as lazy eye, because the affected eye is weaker and often wanders inward or outward.

First, let’s quickly review the physiology of vision. Visual development begins during the first days of life, when the newborn starts receiving visual stimuli from the external world. This helps maturation of the visual pathways connecting the eyes and brain, until they reach maturity at about 4 years of age.

Okay, now, the visual pathways begin in the eye. If we zoom into the wall of the eye, there's an outer fibrous layer, which contains the cornea and sclera, and helps control the focus and entry of light. So the light that passes through the cornea is directed to the lens, which in turn collects light arrays and focuses them into the retina at the back of the eye. The retina houses photoreceptors that translate light into electrical impulses, which are then carried by the optic nerve into the visual cortex of the brain. Finally, the visual cortex processes the impulses coming from both eyes, and fuses them into one clear image.

Now, the causes of amblyopia include any condition that interferes with normal visual development, such as strabismus, or an abnormal alignment of the eyes; astigmatism, which is when light doesn’t focus properly on the retina, causing blurry vision; as well as refractive errors, like near- or farsightedness, and differences in visual acuity between the two eyes. Other causes include eye trauma; ptosis, which is drooping of the upper eyelid; congenital cataract, which is clouding of the eye lens; as well as corneal opacities and eyelid hemangioma. These conditions can also be considered risk factors for amblyopia, along with a family history of amblyopia, premature birth, and neurodevelopmental disorders .

Now, the pathology of amblyopia usually starts when one of the eyes does not correctly receive visual stimuli early in the client’s life. This results in abnormal visual development of the eye’s visual pathways, which prevents them from translating clear images to the visual cortex of the brain. As a result, the visual cortex is not able to fuse these images with the correct images from the unaffected eye, which can cause diplopia or double vision. To avoid diplopia, the visual cortex starts suppressing the impulses coming from the affected eye. So over time, the affected eye becomes weaker. Meanwhile, the other eye is doing all the work, which requires extra effort and, over time, causes eye strain. If untreated, amblyopia can progress to blindness in one or both eyes.

The typical clinical manifestation of amblyopia includes diminished vision in one eye, without pain. Also, clients often have a strong preference for the healthy eye, which is particularly evident when covering their healthy eye. On assessment, the clients may present with wandering eyes, squinting, or head tilting. In addition, the client may bump into things or seem unusually clumsy if they have a poor sense of depth. If untreated, amblyopia can progress to blindness in one or both eyes.

Now, all children should be screened for amblyopia and other visual problems starting at about 6 months of age. The diagnosis of amblyopia starts with the client's history and physical assessment, followed by tests to detect the underlying cause. These tests include the red reflex test, which evaluates conditions causing loss of transparency in the visual axis, such as cataract; as well as the stereopsis test, during which multiple images are shown to the client in order to detect abnormalities of visual acuity, which is typically seen in clients with strabismus.

Another test is the occlusion-objection test, which is when the child’s eyes are covered one at a time, and children with better vision in one eye typically become anxious or irritable when that eye is occluded. And then there's the Titmus test, during which a series of images are shown to the client in order to evaluate their ability to perceive visual depth. Finally, other tests include assessment of visual fixation, by asking the client to to aim their eyes to a specific object or spot, as well as visual acuity testing using the Snellen eye chart.

Treatment of amblyopia typically aims to strengthen the weaker eye, especially during the early years. This can be done by patching the stronger eye for several hours each day, encouraging the client to use the weaker eye in order for it to complete its visual development. Another technique involves the use of atropine drops in the stronger eye to blur its vision, thus encouraging the use of the weaker eye. Glasses can be used to correct refractive errors. Finally, the underlying cause of amblyopia should also be treated, which could include surgery for congenital cataract or severe ptosis.

Key Takeaways

Amblyopia, more commonly referred to as "lazy eye", occurs as a result of a failure of cortical visual development in one or both eyes from eye pathology early in life. It typically results in one eye having markedly better vision than the other. This causes the "weaker" eye to become suppressed. Amblyopia is the most common cause of visual impairment in children.